- Recent Funding
- Investors
- Asabys Partners
Asabys Partners portfolio
Asabys Partners has 8 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.
About this page
It is a venture capital firm based in ES, founded in 2018. It led 3 of the 12 rounds it joined. Its most recent investment on record is AlloX's $10.5M Seed round in October 2026, alongside CDTI Innovación's INNVIERTE program. By category, its portfolio leans toward Health and bio (8). It has co-invested with Ysios Capital, CDTI Innovación's INNVIERTE program and Bpifrance, most often Ysios Capital (4 rounds).
About Asabys Partners
What Asabys Partners invests in
- Health and bio · 8 · 100%
Asabys Partners recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Seed · $10.5M | CDTI Innovación's INNVIERTE program (lead) | ||
| Series B+ · $86.6M | CDTI Innovación's INNVIERTE program, Fund+, Bpifrance +6 | ||
| Seed · $17.37M | APEX Ventures, Amadeus Capital Partners (lead) | ||
| Series B+ · $140M | Gilde Healthcare, EQT Life Sciences (lead), Novartis Venture Fund +5 | ||
| Series B+ · $57M | Panakes Partners (lead), UI Investissement, Aliath Bioventures +6 | ||
| Series A · $85M | CMT Research Foundation, Newton Biocapital, Novo Holdings (lead) +6 | ||
| Series A · $50M · lead | K Fund, UI Investissement, GoHub Ventures +6 | ||
| Series A · $18.17M · lead | CMT Research Foundation, Eli Lilly, Gemma Frisius Fund +4 |
How Asabys Partners invests
Asabys Partners portfolio companies
AAlloX$10.5MSeed · Oct 2026
OOna Therapeutics$86.6MSeries B+ · Oct 2026
IiPremom$17.37MSeed · Sep 2026
SSplice Bio$140MSeries B+ · Jun 2025
DDeepull$57MSeries B+ · Apr 2025
AAugustine Therapeutics$85MSeries A · Mar 2025
QQUIBIM$50MSeries A · Feb 2025
SSidekick Health$55MSeries B+ · May 2022
| Company | Round with Asabys Partners | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Seed · $10.5M | $10.5M | Oct 29, 2026 Seed |
Health and bio |
Series B+ · $86.6M | $120.52M | Oct 5, 2026 Series B+ |
Health and bio |
Seed · $17.37M | $17.37M | Sep 2, 2026 Seed |
Health and bio |
Series B+ · $140M | $197M | Jun 11, 2025 Series B+ |
Health and bio |
Series B+ · $57M | $73.75M | Apr 30, 2025 Series B+ |
Health and bio |
Series A · $85M | $103.17M | Mar 24, 2025 Series A |
Health and bio |
Series A · $50M · lead | $59.73M | Feb 25, 2025 Series A |
Health and bio |
Series B+ · $55M | $75M | May 10, 2022 Series B+ |
Most frequent co-investors
YYsios Capital4 shared rounds · last Oct 5, 2026
CCDTI Innovación's INNVIERTE program2 shared rounds · last Oct 29, 2026
BBpifrance2 shared rounds · last Oct 5, 2026
MMérieux Equity Partners2 shared rounds · last Oct 5, 2026
AAlta Life Sciences2 shared rounds · last Oct 5, 2026
FFund+2 shared rounds · last Oct 5, 2026
CColumbus Venture Partners2 shared rounds · last Oct 5, 2026
NNEA2 shared rounds · last Jun 11, 2025
GGilde Healthcare2 shared rounds · last Jun 11, 2025
NNovartis Venture Fund2 shared rounds · last Jun 11, 2025
UUCB Ventures2 shared rounds · last Jun 11, 2025
UUI Investissement2 shared rounds · last Apr 30, 2025
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
KKorea Credit Guarantee Fund8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TThe Column Group8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
MModi Ventures8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 12 rounds on Recent Funding that name Asabys Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Asabys Partners, which is a subset of its real portfolio. API: /api/v1/investors/asabys-partners (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy